OXCARBAZEPINE

OXCARBAZEPINE was reported 15589 times

OXCARBAZEPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MITOCHONDRIAL DNA MUTATION 33 0.3837
1 SIMPLE PARTIAL SEIZURES 232 0.2875
2 FOCAL DYSCOGNITIVE SEIZURES 312 0.2739
3 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 106 0.2265
4 CSF OLIGOCLONAL BAND PRESENT 20 0.1538
5 EPILEPTIC ENCEPHALOPATHY 27 0.1211
6 LENNOX-GASTAUT SYNDROME 25 0.1101
7 MULTIPLE-DRUG RESISTANCE 329 0.1060
8 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 56 0.1047
9 CENTRAL HYPOTHYROIDISM 32 0.0967
10 POSTICTAL PARALYSIS 21 0.0868
11 MULTIPLE DRUG THERAPY 57 0.0756
12 CREATININE RENAL CLEARANCE INCREASED 51 0.0682
13 PSYCHOGENIC SEIZURE 62 0.0663
14 SEIZURE CLUSTER 54 0.0651
15 COMPLEX PARTIAL SEIZURES 70 0.0629
16 MYOCLONIC EPILEPSY 89 0.0586
17 PETIT MAL EPILEPSY 298 0.0583
18 INFANTILE SPASMS 42 0.0581
19 PROPOFOL INFUSION SYNDROME 40 0.0567
20 PARTIAL SEIZURES 294 0.0561
21 BLOOD GASES ABNORMAL 29 0.0538
22 CHANGE IN SEIZURE PRESENTATION 33 0.0510
23 ATONIC SEIZURES 42 0.0489
24 TEMPORAL LOBE EPILEPSY 21 0.0481
25 AURA 81 0.0434
26 SEDATION COMPLICATION 110 0.0431
27 TONIC CONVULSION 57 0.0402
28 TRIGEMINAL NEURALGIA 160 0.0398
29 HYPOCHLORAEMIA 46 0.0392
30 ANTICONVULSANT DRUG LEVEL DECREASED 54 0.0382
31 HYPERAMMONAEMIC ENCEPHALOPATHY 64 0.0368
32 ELECTROENCEPHALOGRAM ABNORMAL 115 0.0364
33 PLEOCYTOSIS 21 0.0361
34 DRUG WITHDRAWAL CONVULSIONS 62 0.0348
35 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 24 0.0319
36 EPILEPSY 942 0.0308
37 STATUS EPILEPTICUS 336 0.0297
38 CONGENITAL HYDRONEPHROSIS 20 0.0280
39 CRYPTORCHISM 31 0.0276
40 CREATININE RENAL CLEARANCE DECREASED 106 0.0265
41 SEIZURE 2960 0.0256
42 CONVULSION 1465 0.0256
43 BRAIN OPERATION 58 0.0254
44 INTELLECTUAL DISABILITY 38 0.0250
45 GENERALISED TONIC-CLONIC SEIZURE 403 0.0243
46 DEVELOPMENTAL HIP DYSPLASIA 20 0.0240
47 CEREBELLAR ATROPHY 21 0.0238
48 HYPONATRAEMIA 1337 0.0237
49 POSTICTAL STATE 24 0.0231
50 AUTISM 23 0.0226
51 GRAND MAL CONVULSION 209 0.0226
52 ATAXIA 267 0.0225
53 THERAPEUTIC PRODUCT CROSS-REACTIVITY 20 0.0224
54 GAZE PALSY 38 0.0223
55 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 219 0.0213
56 BEHAVIOUR DISORDER 107 0.0198
57 PSYCHOMOTOR RETARDATION 55 0.0196
58 NYSTAGMUS 102 0.0192
59 ANTICONVULSANT DRUG LEVEL INCREASED 31 0.0192
60 BLOOD SODIUM DECREASED 347 0.0184
61 BIPOLAR DISORDER 200 0.0184
62 BIPOLAR I DISORDER 39 0.0178
63 GENE MUTATION 35 0.0177
64 STARING 42 0.0174
65 DYSMORPHISM 40 0.0170
66 PRODUCT SUPPLY ISSUE 121 0.0169
67 TRISOMY 21 21 0.0167
68 CONVERSION DISORDER 32 0.0165
69 BLOOD CHLORIDE DECREASED 42 0.0163
70 DAYDREAMING 25 0.0162
71 SLEEP DEFICIT 34 0.0161
72 ENCEPHALITIS AUTOIMMUNE 21 0.0160
73 RENAL FUNCTION TEST ABNORMAL 69 0.0148
74 EDUCATIONAL PROBLEM 24 0.0144
75 SLEEP PARALYSIS 21 0.0143
76 EXCESSIVE EYE BLINKING 21 0.0142
77 PSYCHOMOTOR SKILLS IMPAIRED 36 0.0137
78 TERMINAL INSOMNIA 24 0.0135
79 SPEECH DISORDER DEVELOPMENTAL 37 0.0129
80 SCHIZOAFFECTIVE DISORDER 23 0.0129
81 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 25 0.0127
82 IMPULSIVE BEHAVIOUR 47 0.0125
83 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 52 0.0125
84 DIPLOPIA 324 0.0125
85 MANIA 203 0.0123
86 HYPOTONIA NEONATAL 19 0.0122
87 SEDATION 316 0.0121
88 HYPERAMMONAEMIA 59 0.0118
89 DIABETIC NEUROPATHY 58 0.0117
90 AMMONIA INCREASED 59 0.0116
91 ENURESIS 46 0.0114
92 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 58 0.0113
93 WRONG PATIENT RECEIVED PRODUCT 33 0.0113
94 AGGRESSION 562 0.0112
95 DRUG LEVEL DECREASED 114 0.0112
96 TONGUE BITING 23 0.0111
97 BLOOD CALCIUM DECREASED 125 0.0111
98 GUN SHOT WOUND 21 0.0111
99 LOGORRHOEA 39 0.0111
100 CATATONIA 57 0.0108
101 COGNITIVE DISORDER 495 0.0106
102 DROOLING 73 0.0106
103 EYE MOVEMENT DISORDER 72 0.0105
104 POLYDIPSIA 41 0.0104
105 CONDUCTION DISORDER 19 0.0104
106 LEARNING DISORDER 25 0.0104
107 STRABISMUS 30 0.0102
108 DYSPHORIA 51 0.0101
109 PARADOXICAL DRUG REACTION 37 0.0100
110 STEVENS-JOHNSON SYNDROME 223 0.0100
111 GRANULOCYTOPENIA 57 0.0100
112 DRUG LEVEL BELOW THERAPEUTIC 55 0.0100
113 NEUROLEPTIC MALIGNANT SYNDROME 118 0.0099
114 PERSONALITY DISORDER 26 0.0099
115 PSYCHOTIC SYMPTOM 20 0.0097
116 ELECTRIC SHOCK SENSATION 27 0.0096
117 GAMBLING DISORDER 26 0.0096
118 SELF INJURIOUS BEHAVIOUR 29 0.0095
119 AFFECTIVE DISORDER 74 0.0094
120 PSYCHOTIC DISORDER 278 0.0094
121 HOMICIDAL IDEATION 38 0.0094
122 HYPOMANIA 34 0.0092
123 AUTONOMIC NERVOUS SYSTEM IMBALANCE 27 0.0092
124 ANTINUCLEAR ANTIBODY POSITIVE 30 0.0092
125 COORDINATION ABNORMAL 128 0.0092
126 ABNORMAL BEHAVIOUR 360 0.0091
127 HYPOTHERMIA 91 0.0090
128 TIC 49 0.0090
129 BRADYKINESIA 53 0.0090
130 CARDIOPULMONARY FAILURE 35 0.0090
131 NORMAL NEWBORN 48 0.0088
132 CLUMSINESS 24 0.0088
133 HAEMORRHAGIC DIATHESIS 31 0.0087
134 PRE-EXISTING CONDITION IMPROVED 54 0.0086
135 DIABETIC COMA 24 0.0086
136 DEVELOPMENTAL DELAY 77 0.0085
137 BALANCE DISORDER 734 0.0085
138 ORTHOSTATIC HYPOTENSION 146 0.0084
139 AUTISM SPECTRUM DISORDER 46 0.0083
140 SCREAMING 53 0.0083
141 IMMUNE THROMBOCYTOPENIA 38 0.0083
142 FACIAL PAIN 74 0.0083
143 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 22 0.0083
144 HALLUCINATION, AUDITORY 131 0.0082
145 APPETITE DISORDER 54 0.0081
146 VENTRICULAR HYPOKINESIA 26 0.0081
147 SUICIDAL BEHAVIOUR 33 0.0079
148 SUSPECTED SUICIDE 37 0.0079
149 ATRIOVENTRICULAR BLOCK FIRST DEGREE 34 0.0078
150 BRAIN NEOPLASM 72 0.0078
151 PSYCHOMOTOR HYPERACTIVITY 129 0.0078
152 HAEMATOLOGICAL INFECTION 19 0.0078
153 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 198 0.0077
154 MOVEMENT DISORDER 246 0.0077
155 TYPE 1 DIABETES MELLITUS 46 0.0076
156 DISORIENTATION 298 0.0075
157 HYPOTONIA 75 0.0075
158 STILLBIRTH 36 0.0074
159 BRUXISM 40 0.0074
160 BRADYPNOEA 20 0.0074
161 FEELING DRUNK 55 0.0074
162 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0074
163 MYOCLONUS 88 0.0074
164 FACE INJURY 28 0.0074
165 NERVOUSNESS 385 0.0074
166 OBSESSIVE-COMPULSIVE DISORDER 59 0.0073
167 SOMNOLENCE 1477 0.0073
168 FEELING OF DESPAIR 34 0.0073
169 DERMATITIS EXFOLIATIVE 36 0.0072
170 DRUG RESISTANCE 184 0.0072
171 POST-TRAUMATIC STRESS DISORDER 48 0.0072
172 VISUAL DISTURBANCE 41 0.0071
173 ARTHRITIS INFECTIVE 33 0.0071
174 MUSCLE CONTRACTIONS INVOLUNTARY 25 0.0071
175 CEREBRAL ATROPHY 28 0.0070
176 DRUG EXPOSURE DURING PREGNANCY 237 0.0070
177 ENCEPHALITIS 48 0.0069
178 HALLUCINATIONS, MIXED 29 0.0069
179 CEREBRAL DISORDER 51 0.0069
180 POTENTIATING DRUG INTERACTION 23 0.0068
181 ABORTION SPONTANEOUS 274 0.0068
182 DEPRESSIVE SYMPTOM 24 0.0068
183 NEONATAL RESPIRATORY DISTRESS SYNDROME 24 0.0068
184 PRODUCT ADMINISTRATION INTERRUPTED 53 0.0067
185 COMPLETED SUICIDE 562 0.0067
186 DRUG INTERACTION 1065 0.0067
187 PANIC DISORDER 26 0.0067
188 THINKING ABNORMAL 125 0.0067
189 AFFECT LABILITY 64 0.0066
190 CYTOLYTIC HEPATITIS 22 0.0066
191 DRUG LEVEL INCREASED 108 0.0065
192 ANGER 219 0.0065
193 GROWTH RETARDATION 19 0.0064
194 ATRIAL SEPTAL DEFECT 54 0.0064
195 MOOD SWINGS 204 0.0064
196 SKIN WARM 37 0.0064
197 IRRITABILITY 381 0.0063
198 SLEEP APNOEA SYNDROME 120 0.0063
199 DEPRESSED LEVEL OF CONSCIOUSNESS 247 0.0062
200 PRODUCT COLOUR ISSUE 32 0.0062
201 APHASIA 188 0.0062
202 DRUG ERUPTION 110 0.0062
203 SPEECH DISORDER 320 0.0061
204 DIFFICULTY IN WALKING 21 0.0061
205 CAESAREAN SECTION 71 0.0061
206 BLOOD LACTIC ACID INCREASED 32 0.0061
207 COMMUNICATION DISORDER 23 0.0060
208 SUICIDE ATTEMPT 364 0.0060
209 SELF-INJURIOUS IDEATION 25 0.0060
210 METABOLIC DISORDER 34 0.0058
211 PARKINSONISM 57 0.0058
212 HEAD INJURY 184 0.0058
213 DYSKINESIA 236 0.0058
214 SUICIDAL IDEATION 527 0.0058
215 BLOOD PROLACTIN INCREASED 27 0.0057
216 DYSARTHRIA 215 0.0057
217 DYSPHEMIA 25 0.0057
218 ATTENTION DEFICIT HYPERACTIVITY DISORDER 24 0.0057
219 PRODUCT SUBSTITUTION ISSUE 328 0.0057
220 RASH MACULO-PAPULAR 126 0.0057
221 SOMNAMBULISM 37 0.0056
222 COLITIS ISCHAEMIC 38 0.0056
223 MENTAL DISORDER 245 0.0056
224 ABORTION INDUCED 53 0.0056
225 PARANOIA 97 0.0056
226 HYPERSOMNIA 161 0.0056
227 SALIVARY HYPERSECRETION 55 0.0055
228 TYPE 2 DIABETES MELLITUS 185 0.0055
229 HYPOGAMMAGLOBULINAEMIA 36 0.0055
230 MAJOR DEPRESSION 40 0.0055
231 MULTIPLE DRUG OVERDOSE 27 0.0054
232 DELUSION 84 0.0054
233 AGITATION 396 0.0054
234 APATHY 78 0.0053
235 DRUG TOXICITY 72 0.0053
236 DISTURBANCE IN ATTENTION 284 0.0053
237 VENTRICULAR SEPTAL DEFECT 30 0.0052
238 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
239 MEMORY IMPAIRMENT 717 0.0052
240 PHOTOPHOBIA 98 0.0052
241 LIQUID PRODUCT PHYSICAL ISSUE 38 0.0052
242 OBESITY 83 0.0052
243 BRAIN OEDEMA 65 0.0051
244 CRYING 187 0.0051
245 COMA 245 0.0051
246 VITAMIN D DEFICIENCY 50 0.0051
247 SCHIZOPHRENIA 62 0.0051
248 DISSOCIATION 39 0.0051
249 HYPERTONIA 29 0.0051
250 MATERNAL EXPOSURE DURING PREGNANCY 451 0.0051
251 RESTLESSNESS 185 0.0050
252 MUSCLE SPASTICITY 62 0.0050
253 BUNDLE BRANCH BLOCK RIGHT 23 0.0050
254 PREGNANCY 100 0.0050
255 HALLUCINATION, VISUAL 105 0.0050
256 POISONING 62 0.0049
257 MOTOR DYSFUNCTION 50 0.0049
258 BRADYPHRENIA 32 0.0049
259 OVERWEIGHT 26 0.0048
260 PRODUCT AVAILABILITY ISSUE 110 0.0048
261 GAMMA-GLUTAMYLTRANSFERASE INCREASED 107 0.0048
262 MOOD ALTERED 131 0.0048
263 DIABETES MELLITUS INADEQUATE CONTROL 85 0.0048
264 NEURALGIA 116 0.0048
265 MUSCLE RIGIDITY 57 0.0048
266 TOXIC ENCEPHALOPATHY 24 0.0047
267 ELECTROLYTE IMBALANCE 55 0.0047
268 PNEUMONIA ASPIRATION 118 0.0047
269 BUNDLE BRANCH BLOCK LEFT 20 0.0047
270 RESPIRATORY ARREST 130 0.0047
271 INTENTIONAL SELF-INJURY 95 0.0047
272 TENDERNESS 49 0.0047
273 HYPERLIPIDAEMIA 56 0.0047
274 PAPULE 33 0.0047
275 DRUG SCREEN POSITIVE 37 0.0047
276 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 256 0.0047
277 URINARY TRACT DISORDER 21 0.0047
278 TARDIVE DYSKINESIA 131 0.0046
279 BLADDER DISORDER 46 0.0046
280 APNOEA 36 0.0046
281 AKATHISIA 63 0.0046
282 HYPERNATRAEMIA 23 0.0046
283 TENSION 28 0.0046
284 SENSORY LOSS 37 0.0046
285 PRODUCT TASTE ABNORMAL 62 0.0046
286 MUSCLE TWITCHING 105 0.0046
287 MENTAL STATUS CHANGES 126 0.0045
288 CYANOSIS 71 0.0045
289 EATING DISORDER 96 0.0045
290 TREMOR 747 0.0045
291 PRESCRIBED OVERDOSE 87 0.0045
292 TOXIC EPIDERMAL NECROLYSIS 68 0.0045
293 BLOOD TRIGLYCERIDES INCREASED 79 0.0045
294 INCREASED APPETITE 85 0.0044
295 SMALL FOR DATES BABY 22 0.0044
296 LOW BIRTH WEIGHT BABY 35 0.0044
297 CONCUSSION 34 0.0044
298 UNRESPONSIVE TO STIMULI 113 0.0044
299 RASH VESICULAR 21 0.0043
300 PSYCHIATRIC SYMPTOM 32 0.0043
301 POISONING DELIBERATE 41 0.0043
302 MENTAL IMPAIRMENT 104 0.0043
303 URINARY INCONTINENCE 127 0.0043
304 ELECTROCARDIOGRAM QT PROLONGED 154 0.0043
305 LETHARGY 245 0.0043
306 DYSGRAPHIA 28 0.0042
307 ORAL PAIN 95 0.0042
308 DECREASED INTEREST 25 0.0042
309 DEPRESSION 962 0.0042
310 DERMATITIS ALLERGIC 53 0.0042
311 PRE-ECLAMPSIA 20 0.0042
312 ASPIRATION 46 0.0042
313 EUPHORIC MOOD 43 0.0042
314 DRUG LEVEL ABOVE THERAPEUTIC 19 0.0041
315 AMNESIA 268 0.0041
316 ANAL INCONTINENCE 37 0.0041
317 ENCEPHALOPATHY 100 0.0041
318 FOETAL EXPOSURE DURING PREGNANCY 331 0.0041
319 ENERGY INCREASED 24 0.0041
320 STOMACH DISCOMFORT 21 0.0041
321 HYPERTHERMIA 31 0.0041
322 FEAR 109 0.0040
323 CONCOMITANT DISEASE AGGRAVATED 25 0.0040
324 VENTRICULAR EXTRASYSTOLES 42 0.0040
325 ANOREXIA 52 0.0040
326 PANIC ATTACK 147 0.0040
327 FORMICATION 28 0.0040
328 PROTHROMBIN TIME PROLONGED 24 0.0040
329 ATRIOVENTRICULAR BLOCK 31 0.0040
330 INCONTINENCE 42 0.0040
331 MATERNAL EXPOSURE BEFORE PREGNANCY 27 0.0039
332 CARDIO-RESPIRATORY ARREST 165 0.0039
333 BLOOD CREATINE PHOSPHOKINASE INCREASED 112 0.0039
334 PERSONALITY CHANGE 36 0.0039
335 VENTRICULAR FIBRILLATION 43 0.0039
336 DYSTONIA 75 0.0039
337 INTENTIONAL OVERDOSE 248 0.0039
338 TONSILLITIS 20 0.0038
339 APLASTIC ANAEMIA 20 0.0038
340 REFUSAL OF TREATMENT BY PATIENT 25 0.0038
341 HALLUCINATION 287 0.0038
342 DIABETES MELLITUS 290 0.0038
343 SOCIAL AVOIDANT BEHAVIOUR 22 0.0038
344 SENSORY DISTURBANCE 61 0.0038
345 HYPOKINESIA 55 0.0038
346 DEPRESSED MOOD 200 0.0038
347 DRUG TOLERANCE 19 0.0038
348 ERYTHEMA MULTIFORME 35 0.0037
349 HEMIPARESIS 63 0.0037
350 FALL 1237 0.0037
351 LOSS OF CONSCIOUSNESS 476 0.0037
352 NEUROTOXICITY 65 0.0037
353 CARDIAC MURMUR 32 0.0037
354 TORSADE DE POINTES 29 0.0037
355 CONFUSIONAL STATE 595 0.0037
356 HEPATOCELLULAR INJURY 52 0.0037
357 HYPOTHYROIDISM 117 0.0037
358 HEMIPLEGIA 30 0.0036
359 RESPIRATORY RATE INCREASED 32 0.0036
360 DRUG DISPENSING ERROR 55 0.0036
361 STREPTOCOCCAL INFECTION 20 0.0036
362 HEPATOMEGALY 35 0.0036
363 SCOLIOSIS 22 0.0035
364 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
365 SOPOR 47 0.0035
366 GENERALISED ERYTHEMA 20 0.0035
367 ANXIETY 999 0.0035
368 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31 0.0035
369 WEIGHT INCREASED 784 0.0035
370 EAR PAIN 68 0.0035
371 SUDDEN DEATH 37 0.0035
372 MULTIPLE SCLEROSIS 167 0.0035
373 VISUAL FIELD DEFECT 25 0.0035
374 ROAD TRAFFIC ACCIDENT 144 0.0034
375 TREATMENT NONCOMPLIANCE 188 0.0034
376 ACCIDENT 41 0.0034
377 GALACTORRHOEA 22 0.0034
378 CENTRAL NERVOUS SYSTEM LESION 47 0.0034
379 MOUTH HAEMORRHAGE 25 0.0034
380 ABASIA 84 0.0034
381 CONJUNCTIVITIS 63 0.0034
382 AGRANULOCYTOSIS 63 0.0034
383 HAND FRACTURE 24 0.0034
384 SLEEP DISORDER 239 0.0034
385 THERAPY NON-RESPONDER 152 0.0034
386 SYNCOPE 335 0.0033
387 DELIRIUM 116 0.0033
388 LEUKOPENIA 167 0.0033
389 SEROTONIN SYNDROME 64 0.0033
390 PRODUCT ADMINISTRATION ERROR 67 0.0033
391 BLOOD ALKALINE PHOSPHATASE INCREASED 82 0.0033
392 EXPOSURE DURING PREGNANCY 204 0.0033
393 CHOLESTASIS 63 0.0033
394 PREMATURE BABY 98 0.0033
395 TOXICITY TO VARIOUS AGENTS 549 0.0033
396 EMOTIONAL DISORDER 100 0.0032
397 PIGMENTATION DISORDER 20 0.0032
398 TRANSAMINASES INCREASED 72 0.0032
399 SLUGGISHNESS 33 0.0032
400 GAIT DISTURBANCE 618 0.0032
401 RHINITIS 26 0.0032
402 PHARYNGITIS 40 0.0032
403 MYDRIASIS 41 0.0032
404 BRAIN INJURY 32 0.0032
405 RETCHING 68 0.0032
406 NIGHTMARE 110 0.0032
407 URINARY RETENTION 106 0.0032
408 VISUAL IMPAIRMENT 393 0.0032
409 MIDDLE INSOMNIA 59 0.0032
410 DIZZINESS 1574 0.0032
411 RENAL CYST 25 0.0031
412 MENINGITIS 21 0.0031
413 PARALYSIS 45 0.0031
414 NERVOUS SYSTEM DISORDER 98 0.0031
415 DYSPHAGIA 298 0.0031
416 INITIAL INSOMNIA 32 0.0031
417 MENISCUS INJURY 19 0.0031
418 HYPERPROLACTINAEMIA 20 0.0031
419 IMPAIRED GASTRIC EMPTYING 42 0.0031
420 RESTLESS LEGS SYNDROME 56 0.0031
421 PANCREATITIS ACUTE 69 0.0031
422 FOOT FRACTURE 58 0.0031
423 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
424 VITAMIN D DECREASED 26 0.0030
425 DERMATITIS BULLOUS 22 0.0030
426 UROSEPSIS 28 0.0030
427 SKIN LACERATION 33 0.0030
428 OSTEOPENIA 46 0.0030
429 TRICUSPID VALVE INCOMPETENCE 24 0.0030
430 HYPERTRANSAMINASAEMIA 21 0.0030
431 HUNGER 42 0.0030
432 FOOD ALLERGY 23 0.0030
433 CARDIAC ARREST 246 0.0030
434 MULTIPLE SCLEROSIS RELAPSE 204 0.0030
435 PETECHIAE 31 0.0030
436 SPINAL OSTEOARTHRITIS 26 0.0030
437 GASTROINTESTINAL DISORDER 265 0.0030
438 NO THERAPEUTIC RESPONSE 36 0.0029
439 GENERAL PHYSICAL CONDITION ABNORMAL 20 0.0029
440 INSOMNIA 784 0.0029
441 RECALLED PRODUCT ADMINISTERED 28 0.0029
442 INCOHERENT 19 0.0029
443 WOUND 82 0.0029
444 CARPAL TUNNEL SYNDROME 41 0.0029
445 VERTIGO 178 0.0029
446 REBOUND EFFECT 33 0.0029
447 DYSSTASIA 85 0.0029
448 THIRST 52 0.0029
449 TREATMENT FAILURE 241 0.0029
450 ANKLE FRACTURE 45 0.0029
451 BEDRIDDEN 38 0.0029
452 PREMATURE DELIVERY 46 0.0029
453 INTERVERTEBRAL DISC PROTRUSION 63 0.0029
454 EOSINOPHIL COUNT INCREASED 24 0.0029
455 TOOTHACHE 52 0.0029
456 LACERATION 27 0.0029
457 MOBILITY DECREASED 206 0.0029
458 ALANINE AMINOTRANSFERASE INCREASED 176 0.0029
459 CONDITION AGGRAVATED 869 0.0029
460 BRADYCARDIA 151 0.0028
461 HYPOKALAEMIA 131 0.0028
462 WITHDRAWAL SYNDROME 119 0.0028
463 LIGAMENT SPRAIN 28 0.0028
464 HEAD DISCOMFORT 50 0.0028
465 TEMPERATURE INTOLERANCE 29 0.0028
466 HYPERAESTHESIA 23 0.0028
467 EAR INFECTION 74 0.0028
468 METABOLIC ACIDOSIS 88 0.0027
469 ASPARTATE AMINOTRANSFERASE INCREASED 146 0.0027
470 RASH GENERALISED 71 0.0027
471 LIPASE INCREASED 21 0.0027
472 MATERNAL DRUGS AFFECTING FOETUS 21 0.0027
473 DISABILITY 54 0.0027
474 CONSTIPATION 595 0.0027
475 PRODUCT PHYSICAL ISSUE 55 0.0027
476 BLOOD CHOLESTEROL INCREASED 127 0.0027
477 IMMUNOSUPPRESSION 24 0.0027
478 MUSCLE TIGHTNESS 44 0.0027
479 ECONOMIC PROBLEM 41 0.0027
480 SINUS BRADYCARDIA 26 0.0027
481 HYDRONEPHROSIS 20 0.0027
482 FEELING ABNORMAL 639 0.0027
483 CHOKING 52 0.0027
484 ORAL DISCOMFORT 37 0.0027
485 MIGRAINE 253 0.0026
486 JOINT DISLOCATION 28 0.0026
487 IMPAIRED DRIVING ABILITY 30 0.0026
488 HEPATIC STEATOSIS 49 0.0026
489 LYMPHADENOPATHY 93 0.0026
490 INTESTINAL OBSTRUCTION 99 0.0026
491 ACTIVITIES OF DAILY LIVING IMPAIRED 52 0.0026
492 EOSINOPHILIA 46 0.0026
493 JOINT INJURY 56 0.0026
494 BLOOD DISORDER 21 0.0026
495 PHARMACEUTICAL PRODUCT COMPLAINT 68 0.0026
496 LEUKOCYTOSIS 47 0.0026
497 HYPOAESTHESIA ORAL 39 0.0026
498 DIABETIC KETOACIDOSIS 62 0.0026
499 VISION BLURRED 349 0.0025
500 THERAPEUTIC RESPONSE UNEXPECTED 114 0.0025
501 DEMENTIA 71 0.0025
502 TOOTH FRACTURE 28 0.0025
503 GASTROENTERITIS 37 0.0025
504 PANCREATITIS 134 0.0025
505 RESPIRATORY TRACT INFECTION 66 0.0025
506 ASTHENIA 947 0.0025
507 GASTRITIS 66 0.0025
508 HAEMODYNAMIC INSTABILITY 19 0.0025
509 ALTERED STATE OF CONSCIOUSNESS 54 0.0025
510 ARRHYTHMIA 118 0.0025
511 HAEMATOCRIT DECREASED 49 0.0025
512 HYPERGLYCAEMIA 90 0.0025
513 RHABDOMYOLYSIS 103 0.0025
514 MUSCLE DISORDER 20 0.0025
515 CARDIOTOXICITY 22 0.0025
516 VOMITING 1159 0.0025
517 QUALITY OF LIFE DECREASED 33 0.0025
518 EXTRAPYRAMIDAL DISORDER 61 0.0025
519 SCAB 28 0.0025
520 DECUBITUS ULCER 20 0.0025
521 APHTHOUS ULCER 19 0.0024
522 POLYURIA 20 0.0024
523 DENTAL CARIES 27 0.0024
524 GASTROENTERITIS VIRAL 44 0.0024
525 SHOCK 56 0.0024
526 VIRAL INFECTION 81 0.0024
527 OVERDOSE 525 0.0024
528 DRUG INTOLERANCE 235 0.0024
529 LIMB INJURY 66 0.0024
530 OSTEOARTHRITIS 103 0.0024
531 BRAIN FOG 38 0.0024
532 DYSURIA 89 0.0024
533 SKIN REACTION 34 0.0024
534 RASH ERYTHEMATOUS 115 0.0024
535 THYROID DISORDER 37 0.0024
536 ABNORMAL DREAMS 66 0.0024
537 IRON DEFICIENCY ANAEMIA 22 0.0024
538 LYMPHOCYTE COUNT DECREASED 42 0.0024
539 ERECTILE DYSFUNCTION 61 0.0024
540 MOUTH ULCERATION 50 0.0024
541 INFUSION SITE ERYTHEMA 20 0.0024
542 SKIN DISORDER 79 0.0024
543 HEADACHE 1479 0.0024
544 WRONG DRUG ADMINISTERED 21 0.0024
545 NEPHROLITHIASIS 108 0.0024
546 RASH 1025 0.0023
547 POLLAKIURIA 98 0.0023
548 NEUTROPHIL COUNT INCREASED 24 0.0023
549 OEDEMA 127 0.0023
550 TACHYCARDIA 208 0.0023
551 UPPER RESPIRATORY TRACT INFECTION 108 0.0023
552 HYPOAESTHESIA 349 0.0023
553 BLOOD POTASSIUM DECREASED 70 0.0023
554 DRUG INEFFECTIVE 3034 0.0023
555 CONTUSION 221 0.0023
556 POST PROCEDURAL COMPLICATION 44 0.0023
557 DRUG PRESCRIBING ERROR 44 0.0023
558 CIRCULATORY COLLAPSE 39 0.0023
559 INSURANCE ISSUE 35 0.0023
560 URINARY TRACT INFECTION 390 0.0023
561 SCAR 39 0.0023
562 ATELECTASIS 22 0.0023
563 SCRATCH 24 0.0023
564 PRESCRIBED UNDERDOSE 45 0.0023
565 BODY TEMPERATURE INCREASED 46 0.0023
566 PYREXIA 777 0.0022
567 BLISTER 126 0.0022
568 THERAPY CHANGE 22 0.0022
569 PRODUCT USE IN UNAPPROVED INDICATION 554 0.0022
570 MUSCULAR WEAKNESS 254 0.0022
571 RASH PAPULAR 50 0.0022
572 SNEEZING 50 0.0022
573 FACIAL PARALYSIS 19 0.0022
574 VISUAL ACUITY REDUCED 74 0.0022
575 IMPAIRED QUALITY OF LIFE 32 0.0022
576 DECREASED ACTIVITY 24 0.0022
577 SEXUAL DYSFUNCTION 26 0.0022
578 INABILITY TO AFFORD MEDICATION 22 0.0022
579 MITRAL VALVE INCOMPETENCE 25 0.0022
580 BLINDNESS 90 0.0022
581 ANURIA 19 0.0022
582 HYPOTENSION 442 0.0022
583 ACUTE RESPIRATORY FAILURE 42 0.0022
584 FEEDING DISORDER 44 0.0022
585 WRIST FRACTURE 26 0.0022
586 CHOLELITHIASIS 71 0.0022
587 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
588 GRIP STRENGTH DECREASED 19 0.0022
589 HYPERTENSIVE CRISIS 24 0.0022
590 HEPATITIS 55 0.0021
591 IRRITABLE BOWEL SYNDROME 46 0.0021
592 RIB FRACTURE 44 0.0021
593 SPINAL PAIN 25 0.0021
594 FATIGUE 1661 0.0021
595 LIP SWELLING 71 0.0021
596 WEIGHT DECREASED 592 0.0021
597 FEELING COLD 59 0.0021
598 CARDIOMEGALY 26 0.0021
599 MUSCULOSKELETAL STIFFNESS 185 0.0021
600 AMENORRHOEA 37 0.0021
601 IMPAIRED WORK ABILITY 45 0.0021
602 SURGERY 123 0.0021
603 PARAESTHESIA 330 0.0021
604 NECK PAIN 117 0.0021
605 WRONG TECHNIQUE IN DRUG USAGE PROCESS 76 0.0021
606 POOR QUALITY SLEEP 45 0.0021
607 HIATUS HERNIA 27 0.0021
608 LIMB DISCOMFORT 64 0.0021
609 INCREASED TENDENCY TO BRUISE 19 0.0021
610 LIVER FUNCTION TEST ABNORMAL 60 0.0021
611 BLOOD PRESSURE ABNORMAL 41 0.0021
612 VENTRICULAR TACHYCARDIA 34 0.0021
613 MALNUTRITION 23 0.0021
614 COLD SWEAT 36 0.0020
615 DRUG-INDUCED LIVER INJURY 64 0.0020
616 OFF LABEL USE 1783 0.0020
617 PRURITUS GENERALISED 44 0.0020
618 HYPOPHAGIA 52 0.0020
619 COVID-19 PNEUMONIA 24 0.0020
620 BACK INJURY 22 0.0020
621 DISEASE RECURRENCE 96 0.0020
622 FACE OEDEMA 34 0.0020
623 PHARYNGEAL OEDEMA 31 0.0020
624 MICTURITION URGENCY 23 0.0020
625 UPPER LIMB FRACTURE 40 0.0020
626 PRODUCT ODOUR ABNORMAL 21 0.0020
627 BURNING SENSATION 140 0.0020
628 HYPERHIDROSIS 257 0.0020
629 OSTEOPOROSIS 82 0.0020
630 OXYGEN SATURATION DECREASED 112 0.0020
631 RESPIRATORY DISTRESS 55 0.0020
632 HEART RATE IRREGULAR 45 0.0020
633 HYPERTENSION 421 0.0020
634 THERAPY PARTIAL RESPONDER 31 0.0020
635 LOWER LIMB FRACTURE 38 0.0020
636 RESPIRATORY FAILURE 144 0.0020
637 END STAGE RENAL DISEASE 36 0.0020
638 ACCIDENTAL OVERDOSE 72 0.0020
639 DIZZINESS POSTURAL 19 0.0020
640 SUBDURAL HAEMATOMA 28 0.0020
641 WHITE BLOOD CELL COUNT INCREASED 75 0.0020
642 PALLOR 53 0.0019
643 DRUG ABUSE 162 0.0019
644 FIBROMYALGIA 47 0.0019
645 HYPERBILIRUBINAEMIA 20 0.0019
646 DERMATITIS CONTACT 22 0.0019
647 DRUG ADMINISTRATION ERROR 59 0.0019
648 HEPATIC ENZYME INCREASED 131 0.0019
649 NEUROPATHY PERIPHERAL 182 0.0019
650 SEASONAL ALLERGY 27 0.0019
651 HEPATITIS C 23 0.0019
652 CHROMATURIA 43 0.0019
653 SINUS TACHYCARDIA 27 0.0019
654 GASTRIC DISORDER 65 0.0019
655 NERVE INJURY 21 0.0019
656 ULCER 30 0.0019
657 EYE DISORDER 62 0.0019
658 RESPIRATORY DEPRESSION 23 0.0019
659 TINNITUS 86 0.0019
660 EYELID PTOSIS 19 0.0019
661 PRODUCT USE ISSUE 351 0.0019
662 UNEVALUABLE EVENT 141 0.0019
663 RASH MACULAR 65 0.0019
664 HYPERSENSITIVITY 345 0.0019
665 MEDICATION ERROR 103 0.0019
666 THERAPY CESSATION 95 0.0018
667 HYPOCALCAEMIA 35 0.0018
668 TOOTH EXTRACTION 23 0.0018
669 RHINORRHOEA 119 0.0018
670 TACHYPNOEA 25 0.0018
671 RESPIRATORY DISORDER 55 0.0018
672 BLOOD PRESSURE DECREASED 122 0.0018
673 LIVER INJURY 45 0.0018
674 MYOCARDITIS 21 0.0018
675 CHEST PAIN 339 0.0018
676 INTENTIONAL DOSE OMISSION 52 0.0018
677 HEPATIC FUNCTION ABNORMAL 68 0.0018
678 PHOTOSENSITIVITY REACTION 30 0.0018
679 DERMATITIS 38 0.0018
680 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 129 0.0018
681 BRONCHITIS 134 0.0018
682 SKIN DISCOLOURATION 83 0.0018
683 PARAESTHESIA ORAL 26 0.0018
684 DRUG EFFECT INCOMPLETE 65 0.0018
685 DRUG WITHDRAWAL SYNDROME 157 0.0018
686 DRY EYE 89 0.0018
687 DEHYDRATION 236 0.0018
688 CHILLS 207 0.0018
689 INJURY 124 0.0018
690 THROAT IRRITATION 79 0.0018
691 DEAFNESS 46 0.0018
692 STAPHYLOCOCCAL INFECTION 58 0.0018
693 PERIPHERAL COLDNESS 24 0.0017
694 IMMUNODEFICIENCY 26 0.0017
695 FRACTURE 33 0.0017
696 NEOPLASM 20 0.0017
697 GASTROOESOPHAGEAL REFLUX DISEASE 140 0.0017
698 BLOOD UREA INCREASED 29 0.0017
699 FEELING JITTERY 33 0.0017
700 SWOLLEN TONGUE 54 0.0017
701 HEART RATE INCREASED 171 0.0017
702 BONE MARROW FAILURE 35 0.0017
703 FOOT DEFORMITY 19 0.0017
704 GLAUCOMA 33 0.0017
705 NAUSEA 1356 0.0017
706 MUSCLE SPASMS 313 0.0017
707 SWELLING FACE 111 0.0017
708 C-REACTIVE PROTEIN INCREASED 62 0.0017
709 THERAPEUTIC RESPONSE DECREASED 103 0.0017
710 LYMPHOPENIA 24 0.0017
711 CYST 21 0.0017
712 HEPATIC FAILURE 51 0.0017
713 PRODUCT DOSE OMISSION ISSUE 497 0.0017
714 DECREASED APPETITE 392 0.0017
715 ADVERSE DRUG REACTION 151 0.0017
716 ABDOMINAL DISCOMFORT 282 0.0017
717 THROMBOCYTOPENIA 188 0.0017
718 RED BLOOD CELL COUNT DECREASED 48 0.0017
719 CARDIOGENIC SHOCK 24 0.0017
720 DRY MOUTH 135 0.0017
721 TRANSIENT ISCHAEMIC ATTACK 56 0.0017
722 DRUG EFFECT DECREASED 89 0.0017
723 SINUSITIS 169 0.0016
724 PRURITUS 632 0.0016
725 SKIN LESION 45 0.0016
726 TOOTH LOSS 34 0.0016
727 ROTATOR CUFF SYNDROME 21 0.0016
728 BLOOD PRESSURE INCREASED 250 0.0016
729 MALAISE 717 0.0016
730 EYELID OEDEMA 19 0.0016
731 SEPTIC SHOCK 71 0.0016
732 INFLUENZA LIKE ILLNESS 134 0.0016
733 CARDIOMYOPATHY 24 0.0016
734 RASH PRURITIC 88 0.0016
735 PALPITATIONS 190 0.0016
736 CHRONIC KIDNEY DISEASE 122 0.0016
737 PERICARDIAL EFFUSION 37 0.0016
738 ANHEDONIA 42 0.0016
739 PRODUCT USE COMPLAINT 25 0.0016
740 HAEMATOMA 41 0.0016
741 MASS 22 0.0016
742 GALLBLADDER DISORDER 28 0.0016
743 UNDERDOSE 114 0.0016
744 FLUSHING 158 0.0016
745 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
746 BLOOD POTASSIUM INCREASED 25 0.0015
747 CYSTITIS 49 0.0015
748 PAIN 941 0.0015
749 INTENTIONAL PRODUCT MISUSE 134 0.0015
750 KIDNEY INFECTION 30 0.0015
751 MENORRHAGIA 30 0.0015
752 RENAL DISORDER 71 0.0015
753 ABDOMINAL PAIN 354 0.0015
754 INFLUENZA 169 0.0015
755 HYPOMAGNESAEMIA 21 0.0015
756 BLOOD TEST ABNORMAL 21 0.0015
757 LIVER DISORDER 66 0.0015
758 PRODUCT QUALITY ISSUE 202 0.0015
759 MUSCULOSKELETAL CHEST PAIN 23 0.0015
760 PNEUMONIA 481 0.0015
761 OROPHARYNGEAL PAIN 137 0.0015
762 ERYTHEMA 304 0.0015
763 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 71 0.0015
764 ILLNESS 152 0.0015
765 SWELLING 138 0.0015
766 PRODUCT DOSE OMISSION 96 0.0015
767 HAEMATEMESIS 37 0.0015
768 RENAL FAILURE 193 0.0015
769 CEREBRAL HAEMORRHAGE 52 0.0015
770 ABDOMINAL PAIN UPPER 299 0.0015
771 CEREBROVASCULAR ACCIDENT 245 0.0014
772 MULTI-ORGAN FAILURE 25 0.0014
773 LIVER FUNCTION TEST INCREASED 31 0.0014
774 OEDEMA PERIPHERAL 176 0.0014
775 WHITE BLOOD CELL COUNT DECREASED 156 0.0014
776 TOOTH DISORDER 32 0.0014
777 URTICARIA 241 0.0014
778 SYSTEMIC LUPUS ERYTHEMATOSUS 51 0.0014
779 GAIT INABILITY 48 0.0014
780 INTENTIONAL DRUG MISUSE 30 0.0014
781 ECZEMA 75 0.0014
782 ADVERSE REACTION 19 0.0014
783 SKIN FISSURES 28 0.0014
784 CELLULITIS 72 0.0014
785 LUNG DISORDER 70 0.0014
786 SKIN EXFOLIATION 120 0.0014
787 GYNAECOMASTIA 44 0.0014
788 SKIN HAEMORRHAGE 21 0.0014
789 SINUS DISORDER 28 0.0014
790 ANAPHYLACTIC REACTION 78 0.0014
791 PULMONARY MASS 21 0.0014
792 BLOOD CREATININE INCREASED 92 0.0014
793 INTENTIONAL PRODUCT USE ISSUE 123 0.0014
794 WHEEZING 83 0.0014
795 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 73 0.0014
796 SPINAL FRACTURE 28 0.0014
797 HEART RATE DECREASED 49 0.0014
798 ACUTE HEPATIC FAILURE 19 0.0014
799 ABDOMINAL PAIN LOWER 35 0.0014
800 COMPLICATION ASSOCIATED WITH DEVICE 20 0.0014
801 LOCAL SWELLING 24 0.0014
802 PAIN IN EXTREMITY 405 0.0014
803 EYE IRRITATION 79 0.0014
804 BONE DISORDER 25 0.0014
805 MYALGIA 233 0.0014
806 DEVICE RELATED INFECTION 21 0.0014
807 HYPOXIA 48 0.0014
808 HOSPITALISATION 209 0.0014
809 PANCYTOPENIA 76 0.0014
810 FLATULENCE 77 0.0014
811 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 275 0.0014
812 DYSPNOEA 768 0.0014
813 DYSPEPSIA 133 0.0014
814 DIVERTICULITIS 37 0.0013
815 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
816 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
817 EYE PAIN 75 0.0013
818 CHEST DISCOMFORT 136 0.0013
819 DRUG DOSE OMISSION 219 0.0013
820 FUNGAL INFECTION 44 0.0013
821 RENAL FAILURE ACUTE 56 0.0013
822 MENSTRUATION IRREGULAR 35 0.0013
823 PAIN IN JAW 37 0.0013
824 COUGH 364 0.0013
825 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38 0.0013
826 BLOOD BILIRUBIN INCREASED 35 0.0013
827 DIARRHOEA 830 0.0013
828 NASOPHARYNGITIS 237 0.0013
829 HAEMATURIA 44 0.0013
830 DRUG EFFECT LESS THAN EXPECTED 19 0.0013
831 HAEMORRHOIDS 25 0.0013
832 BACK PAIN 297 0.0013
833 HYPOGLYCAEMIA 62 0.0013
834 HAEMORRHAGE INTRACRANIAL 19 0.0013
835 EPISTAXIS 95 0.0013
836 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90 0.0013
837 ACUTE KIDNEY INJURY 192 0.0013
838 PLEURAL EFFUSION 76 0.0012
839 RENAL INJURY 37 0.0012
840 SKIN ULCER 32 0.0012
841 PRESYNCOPE 30 0.0012
842 SEPSIS 137 0.0012
843 FEELING HOT 75 0.0012
844 BLOOD PRESSURE FLUCTUATION 29 0.0012
845 PRODUCT DOSE OMISSION IN ERROR 34 0.0012
846 DYSPHONIA 70 0.0012
847 INFECTION 173 0.0012
848 GENERAL PHYSICAL HEALTH DETERIORATION 138 0.0012
849 ILL-DEFINED DISORDER 72 0.0012
850 ISCHAEMIC STROKE 21 0.0012
851 PRODUCT PRESCRIBING ERROR 28 0.0012
852 ABDOMINAL DISTENSION 122 0.0012
853 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
854 DISCOMFORT 71 0.0012
855 PULMONARY OEDEMA 52 0.0012
856 FLUID RETENTION 59 0.0012
857 MUSCULOSKELETAL DISORDER 22 0.0012
858 PULMONARY EMBOLISM 109 0.0011
859 APPLICATION SITE ERYTHEMA 30 0.0011
860 INFLAMMATION 59 0.0011
861 CARDIOVASCULAR DISORDER 29 0.0011
862 COAGULOPATHY 19 0.0011
863 HERNIA 22 0.0011
864 COVID-19 199 0.0011
865 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
866 NEUTROPHIL COUNT DECREASED 46 0.0011
867 ORAL HERPES 22 0.0011
868 BONE PAIN 66 0.0011
869 METRORRHAGIA 19 0.0011
870 HYPERKALAEMIA 39 0.0011
871 THROAT TIGHTNESS 30 0.0011
872 ADVERSE EVENT 102 0.0011
873 GASTRIC ULCER 21 0.0011
874 PROTEINURIA 21 0.0011
875 BLOOD GLUCOSE DECREASED 53 0.0011
876 HERPES ZOSTER 63 0.0011
877 ANAEMIA 209 0.0011
878 THERAPEUTIC PRODUCT EFFECT DECREASED 49 0.0011
879 CATARACT 65 0.0011
880 BLOOD GLUCOSE ABNORMAL 20 0.0011
881 HAEMOGLOBIN DECREASED 111 0.0011
882 ALOPECIA 212 0.0011
883 ASTHMA 122 0.0011
884 JAUNDICE 29 0.0011
885 NEUTROPENIA 144 0.0011
886 CARDIAC DISORDER 99 0.0011
887 PULMONARY HYPERTENSION 22 0.0011
888 STOMATITIS 64 0.0011
889 NIGHT SWEATS 34 0.0011
890 INTERSTITIAL LUNG DISEASE 51 0.0011
891 EXPIRED PRODUCT ADMINISTERED 35 0.0011
892 THERAPY INTERRUPTED 75 0.0010
893 ARTHRITIS 82 0.0010
894 PLATELET COUNT DECREASED 111 0.0010
895 DYSGEUSIA 77 0.0010
896 TASTE DISORDER 21 0.0010
897 FEMUR FRACTURE 32 0.0010
898 OCULAR HYPERAEMIA 49 0.0010
899 RECTAL HAEMORRHAGE 44 0.0010
900 DISEASE PROGRESSION 121 0.0010
901 NASAL CONGESTION 60 0.0010
902 BACTERIAL INFECTION 19 0.0010
903 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
904 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 181 0.0010
905 APPLICATION SITE PAIN 22 0.0010
906 PRODUCTIVE COUGH 47 0.0010
907 COLITIS 37 0.0010
908 ACNE 74 0.0010
909 ANGIOEDEMA 43 0.0010
910 INCORRECT DOSE ADMINISTERED 221 0.0010
911 EYE SWELLING 36 0.0010
912 HAEMORRHAGE 101 0.0010
913 HIP FRACTURE 31 0.0010
914 CORONARY ARTERY DISEASE 29 0.0010
915 MUSCULOSKELETAL PAIN 50 0.0010
916 DEEP VEIN THROMBOSIS 62 0.0010
917 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
918 ARTHRALGIA 393 0.0009
919 ATRIAL FIBRILLATION 92 0.0009
920 VAGINAL HAEMORRHAGE 41 0.0009
921 EMOTIONAL DISTRESS 114 0.0009
922 HAEMOPTYSIS 26 0.0009
923 DYSPNOEA EXERTIONAL 35 0.0009
924 LACRIMATION INCREASED 28 0.0009
925 JOINT SWELLING 110 0.0009
926 LOCALISED INFECTION 22 0.0009
927 ANGINA PECTORIS 26 0.0009
928 HOT FLUSH 68 0.0009
929 HEPATOTOXICITY 20 0.0009
930 GLOSSODYNIA 20 0.0009
931 NEEDLE ISSUE 26 0.0009
932 RENAL IMPAIRMENT 75 0.0009
933 PERIPHERAL SWELLING 136 0.0009
934 HYPOACUSIS 38 0.0009
935 FAECES DISCOLOURED 19 0.0009
936 BLOOD GLUCOSE INCREASED 165 0.0009
937 DRY SKIN 116 0.0009
938 INJECTION SITE MASS 32 0.0009
939 HAEMATOCHEZIA 47 0.0009
940 ACUTE MYOCARDIAL INFARCTION 25 0.0008
941 THROMBOSIS 68 0.0008
942 AGEUSIA 21 0.0008
943 CARDIAC FAILURE 67 0.0008
944 CEREBRAL INFARCTION 20 0.0008
945 RHEUMATOID ARTHRITIS 92 0.0008
946 JOINT STIFFNESS 21 0.0008
947 NEOPLASM MALIGNANT 53 0.0008
948 GLYCOSYLATED HAEMOGLOBIN INCREASED 20 0.0008
949 MYOCARDIAL INFARCTION 131 0.0008
950 NO ADVERSE EVENT 135 0.0007
951 ARTHROPATHY 41 0.0007
952 PRODUCT ADHESION ISSUE 26 0.0007
953 DRUG DEPENDENCE 117 0.0007
954 PROCEDURAL PAIN 20 0.0007
955 LABORATORY TEST ABNORMAL 21 0.0007
956 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
957 IMPAIRED HEALING 22 0.0007
958 INJECTION SITE RASH 20 0.0007
959 LACTIC ACIDOSIS 21 0.0006
960 DEVICE ISSUE 58 0.0006
961 GASTROINTESTINAL HAEMORRHAGE 54 0.0006
962 DERMATITIS ATOPIC 34 0.0006
963 BONE DENSITY DECREASED 20 0.0006
964 INJECTION SITE SWELLING 48 0.0006
965 CARDIAC FAILURE CONGESTIVE 50 0.0006
966 PSORIASIS 81 0.0006
967 INJECTION SITE REACTION 42 0.0006
968 EXTRA DOSE ADMINISTERED 24 0.0006
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 20 0.0006
970 DEATH 502 0.0006
971 INJECTION SITE PRURITUS 39 0.0006
972 DEVICE LEAKAGE 25 0.0006
973 DEVICE DISLOCATION 25 0.0006
974 EYE PRURITUS 19 0.0006
975 INJECTION SITE ERYTHEMA 70 0.0006
976 INJECTION SITE PAIN 170 0.0006
977 INJECTION SITE BRUISING 43 0.0005
978 PRODUCT STORAGE ERROR 47 0.0005
979 INJECTION SITE HAEMORRHAGE 41 0.0005
980 SKIN IRRITATION 23 0.0005
981 SKIN BURNING SENSATION 35 0.0005
982 COLITIS ULCERATIVE 21 0.0005
983 DEVICE BREAKAGE 19 0.0005
984 INFUSION RELATED REACTION 31 0.0005
985 DEVICE MALFUNCTION 31 0.0004
986 DEVICE EXPULSION 28 0.0004
987 BREAST CANCER 35 0.0004
988 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
989 FEBRILE NEUTROPENIA 21 0.0003
990 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
991 DRUG DOSE OMISSION BY DEVICE 19 0.0002